CoreWeave, Inc. (CRWV)
Verdict history · CRWV
Every call Verdix has made on CRWV.
While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.
Click any date below to read that write-up
The prior SELL verdict at $105.26 was driven by a panel with zero bullish voices, where the intrinsic-value and GARP frameworks both saw overvaluation and the Forensic Skeptic flagged the balance sheet as existential. The stock has since fallen 16.5% to $87.85, moving into the $78-80 zone where the value-oriented framework now sees fair value but not yet a bargain. The trigger to flip to BUY, positive free cash flow, D/E below 3x, or insider buying, has not fired, and the addition of the Disruptive-Innovation Seeker as a lone Bull is offset by two Bears now framing the downside in more explicit terms. The panel shifted from unanimous caution to a genuine split, downgrading conviction from HIGH to MEDIUM and the verdict from SELL to BALANCED.
See methodology for how verdicts are produced. Full track record →
The panel’s case against CRWV — and where they disagree.
The case against outweighs the case for at today's price.
NASDAQ · AI Cloud Infrastructure / Neocloud · 2026-07-01 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
SellMEDIUM confidence
Why
Six investing legends on the levered neocloud, down ~53% from its post-IPO high: a real $99B backlog and 112% revenue growth on one side; ~$25B of debt, ~25% of revenue eaten by interest, a 2026 refinancing wall, and a largest customer (Meta) turning into a competitor on the other. A broken tape meets a stretched balance sheet. The debate and the key levels.Level to watch
Key support 80−7.5% from 86.48
The panel's take
Verdict: SELL · Conviction: MEDIUM · Last price: USD 86.48 (as of 2026-07-01)
CoreWeave is the batch's most bearish call, and the reason is the balance sheet as much as the chart. The growth is real — Q1 revenue more than doubled (+112%) to $2.08B, and the contracted backlog swelled to $99.4B (OpenAI, Meta, Microsoft, Anthropic) — but this is a leveraged, depreciating-asset business, not a software story. It carries roughly $25-30B of debt against a thin equity cushion, interest expense of $536M in a single quarter consumed about a quarter of revenue, adjusted operating margin collapsed from 17% to ~1%, the GAAP loss widened to $740M, free cash flow ran about -$4.7B in the quarter, and a $4.2B debt maturity looms in 2026 against only ~$2-3B of cash (a 0.31 current ratio). The tape reflects it: down ~53% from the ~$185 post-IPO high, below its trend, on a fresh Supertrend sell — a Stage-4 decline the macro lens calls "a falling knife." Then, on July 1, the catalyst that dropped it another ~13%: Meta — a top-three backlog customer — is reportedly building "Meta Compute" to resell its own capacity, i.e. the customer becoming a competitor. Five of six frameworks are bearish, three at high conviction, several warning of genuine permanent-loss risk if the refinancing or demand assumptions slip. The counterweight is real — the stock is already halved, it's far cheaper than peer Nebius on an enterprise-value basis, and the backlog is take-or-pay — which is why conviction is MEDIUM and one lens reads it as merely fairly priced. But on the weight of a broken tape, a stretched balance sheet, and a fresh competitive threat, the synthesis is SELL.
Key levels
Key levels · CRWV
USD · as of 2026-07-01Analyst consensus target 140 USD · range 45–170
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance starts at ~$98-100 (round-number, near the broken trend that has flipped to overhead supply), then a ~$120 mid-range swing, up to a ~$150-160 distribution zone that would require a full trend reversal to reach. Key support sits at ~$80-82 (a near-term round-number shelf), then ~$67 (near the 52-week low around $64 and a mid-range air pocket), with a deeper IPO-era reference near ~$45. The analyst consensus target spans an enormous USD 45 to 170 (some models run higher still), averaging around USD 140 — well above the price, but those targets largely predate both the Meta Compute news and the neocloud de-rating, so treat the gap as stale rather than as margin of safety; the panel's own value estimates ($55-117) sit far lower.
What legendary investors think
We ran CoreWeave past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue🔴 BearishHigh
"This is renting out GPUs — no brand, no network effect, no switching cost a hyperscaler with its own capital can't route around." $24.9B of debt against depreciating hardware, $536M of quarterly interest, a loss that *widened* to $740M as revenue doubled: "a company that loses more money the faster it grows." Microsoft at ~67% of revenue is "a single point of failure, not a moat." Down 50% "isn't a margin of safety on earnings that don't exist."
The GARP OperatorGrowth (GARP)🔴 BearishHigh
"A GPU landlord with more debt than equity and no earnings to run through my PEG formula." Debt-to-equity north of 6x means "it can NOT always survive a downturn" — the opposite of the cash-rich, low-debt businesses he sleeps on. FCF burning ~$4.7B a quarter; "$536M of interest means most of every new revenue dollar goes to bondholders before shareholders see a dime." A permanent-capital-destruction setup — pass.
The Disruptive-Innovation SeekerGrowth🟢 BullishMedium
"The market is voting with contracted dollars" — a $99.4B backlog (up from $66.8B a quarter earlier), 112% growth, $18-19B exit ARR guided. The terrifying balance sheet is "the capital intensity you'd expect financing the picks-and-shovels of the biggest platform shift since the internet." 5-year base case ~$350-450 — but concedes a sub-$30 bear case "if the debt-funded buildout collides with a demand air pocket."
The Intrinsic-Value ModelerValuation🔴 BearishMed-High
"The equity is a levered residual — small EBIT changes swing it 2-3x." A capital-intensive infrastructure operator whose adjusted operating margin fell from 17% to 1% while revenue doubled: "the unit economics are worse than the growth headline suggests." Through-cycle fair value ~$55-65 (25-35% downside), with a bear case near $25 — "growth without profitability, funded by debt, is a leveraged bet on GPU demand, not a moat."
The Forensic SkepticContrarian🔴 BearishHigh
"I can't get comfortable with any floor." The $99B backlog is contracted revenue, not cash, sitting atop ~$25B debt plus ~$34B of off-balance-sheet leases; a $4.2B maturity is due in 2026 as GPU rental rates have fallen 50-70%, denting the collateral — "covenant trips flagged as possible by 2027." Microsoft ~67%, Nvidia both largest shareholder and supplier ("circular financing"), FCF -$4.7B: "a duration mismatch I've seen blow up before."
The Macro OpportunistMacro🔴 BearishMed-High
"A falling knife, not a buy." Down 50%+, off another 13% today on the Meta report, dragging the whole neocloud group — "that's a sector re-rating, and you get out of the way, you don't average in." With the Fed done cutting (maybe hiking), "the most levered, most-financed, negative-FCF names get killed first." Would wait for a multi-week base above $70-75 with volume drying up before even a trade — "home runs come from buying strength after the dust settles."
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The top line and backlog are genuinely strong: revenue +112%, a $99.4B contracted backlog, reaffirmed $12-13B FY2026 guidance.
- The balance sheet is the central risk: ~$25-30B of debt, ~25% of revenue consumed by interest, a 0.31 current ratio, and a $4.2B maturity due in 2026 against ~$2-3B of cash.
- The economics are deteriorating even as revenue grows: adjusted operating margin fell from 17% to ~1%, the GAAP loss widened, and free cash flow ran about -$4.7B in the quarter.
- The tape is broken — a Stage-4 decline ~53% off the high — and the Meta Compute report is a genuine, not cosmetic, threat to the neocloud demand thesis.
The real debate
- Priced-in or more to fall? Bulls (and the valuation-on-EV read) note the stock is already halved and cheap versus Nebius (~5-6x EV/revenue vs ~60-70x sales); the levered-residual and quality lenses see fair value still below the price with real refinancing risk.
- Backlog durability. The $99B is take-or-pay and hard to cancel near-term; but Meta building competing capacity signals hyperscalers may backward-integrate rather than expand future orders.
- Can it self-fund? Bulls trust backlog-to-cash conversion; bears see a business that needs continuous capital-market access to service debt and fund $31-35B of 2026 capex — fragile if credit tightens.
The question it comes down to: Is CoreWeave an early leader in AI infrastructure whose $99B backlog and post-crash valuation offer asymmetric upside — or a highly levered, negative-cash-flow GPU landlord with a refinancing wall, a customer becoming a competitor, and fair value still below the price, where "cheap" is a value trap until the balance sheet is de-risked?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 86.48 / ~47B |
| EV / fwd revenue | ~5–6x (EV ~$70–72B incl. ~$25–27B net debt) — vs Nebius ~60–70x P/S |
| Revenue (Q1 2026) | USD 2.08B (+112% YoY); FY2026 guide $12–13B; exit ARR $18–19B |
| Margins | Gross ~68% (down from 78%); adj. operating ~1% (from 17%); GAAP net loss -$740M |
| Interest / FCF | Interest ~$536M/qtr (~25% of revenue); free cash flow ~-$4.7B/qtr |
| Debt / liquidity | Debt ~$25–30B; current ratio 0.31; $4.2B maturity due 2026 vs ~$2–3B cash |
| Backlog / concentration | ~$99.4B contracted (Microsoft ~67% of FY2025 revenue; OpenAI ~$22B; Meta ~$21–35B) |
Figures as of Q1 2026 (quarter ended March 31, reported May 7) / July 1, 2026; sourced from CoreWeave IR/SEC filings, CNBC, Motley Fool, 24/7 Wall St, MarketBeat, Bloomberg via news coverage. Total debt figures vary by source ($25-30B depending on capital-lease inclusion) — flagged, not resolved. The debt inflates enterprise value relative to market cap, so EV/revenue (~5-6x) is the more honest cross-comparison than the 8x trailing P/S — and the reason CRWV screens "cheap" versus Nebius. The Meta Compute report (July 1) is a Bloomberg story with no disclosed pricing or launch — an emerging risk, not yet a confirmed fact pattern; existing take-or-pay contracts are near-term unaffected. Analyst consensus ($135-140 average) predates the news.
The bottom line
CoreWeave is the panel's clearest case of a real growth story colliding with a stretched balance sheet and a broken tape. The bull facts are genuine: revenue up 112%, a $99.4B take-or-pay backlog anchored by OpenAI, Microsoft, Meta, and Anthropic, and — after a ~53% crash — a valuation that, on enterprise value, is a fraction of peer Nebius's. That's enough for the innovation lens to underwrite a multi-year $350-450 case and for the fundamental read to call it "priced-in" rather than expensive. But five of six frameworks, three at high conviction, see a business that loses more money the faster it grows: ~$25-30B of debt, roughly a quarter of revenue consumed by interest, adjusted operating margin collapsing from 17% to 1%, ~$4.7B of quarterly cash burn, and a $4.2B maturity due in 2026 against ~$2-3B of cash — a duration mismatch (long-lived debt against fast-depreciating GPUs whose rental rates have already fallen 50-70%) that the value, GARP, and forensic lenses flag as genuine permanent-loss risk, not just volatility. Layer on ~67% Microsoft revenue concentration, Nvidia sitting on both sides as shareholder and supplier, $3.4B of post-lockup insider selling with zero buys, a Stage-4 chart the macro lens won't touch, and a largest customer now building the competing product, and the balance of risks skews down. What would change the call is a clean refinancing of the 2026 maturity at reasonable rates, margins recovering toward the guided long-term target, and evidence Meta Compute is additive rather than substitutive. What keeps it a sell is that, until the balance sheet is de-risked, "cheap" is a levered bet on continuous capital-market access into a tightening Fed and a broken tape — and the same backlog would be far safer to own once the financing and demand questions are answered. The stock is already halved and the backlog is real, which is why conviction is Medium rather than high — but the direction of least resistance is still lower.
contact@verdixhq.com · Published 2026-07-01 · Prices as of 2026-07-01 · Time horizon: 3–12 months · No direct position held in CRWV · CRWV verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s case against CRWV — and where they disagree.
The case against outweighs the case for at today's price.
NASDAQ · Technology / AI Cloud Infrastructure · 2026-07-11 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
SellMEDIUM confidence
Why
Six investing legends on CoreWeave, the debt-financed GPU cloud down ~46% from its high: a real $99B backlog and 112% revenue growth, but ~$25B+ of debt, ~$2.1B of annual interest, widening losses, and its biggest customer (Microsoft, ~two-thirds of revenue) de-prioritizing it for a rival. Five of six lenses see the leverage overwhelming the story. The debate and the key levels.Level to watch
Key support 85−4.4% from 88.88
The panel's take
Verdict: SELL · Conviction: MEDIUM · Last price: USD 88.88 (as of 2026-07-11)
CoreWeave is the panel's most bearish call — five of six lenses see a genuinely explosive AI-infrastructure business whose debt-financed balance sheet and customer concentration overwhelm the growth. The demand is real: Q1 2026 revenue grew 112% to $2.08B, and the revenue backlog reached $99.4B on multi-year take-or-pay contracts with Microsoft, OpenAI, Meta, and Anthropic. But the financing model behind it is what alarms the panel. CoreWeave carries roughly $25B of debt (over $35B including lease obligations), pays about $536M of interest per quarter (~$2.1B annualized), posted a widening $740M net loss, and burned billions of free cash flow against multi-billion quarterly capex — a "depreciation treadmill" where interest and depreciation together consume most of revenue before operating costs. Layered on top is acute concentration: Microsoft has driven roughly two-thirds of revenue, and it recently passed on expanding with CoreWeave, signing instead with a rival — the exact single-customer risk the bears warned about. The intrinsic-value work lands fair value around $35-45, roughly half the price, and the tape confirms the deterioration (below the 50- and 200-day, a fresh death cross). With the balance sheet, the customer picture, and the chart all pointing the same way, the synthesis is SELL.
Key levels
Key levels · CRWV
USD · as of 2026-07-11Analyst consensus target 135 USD · range 45–250
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance starts at ~$112 (the April swing high and recent supply), then ~$135-138 (the October high), up to the ~$185 all-time high from June 2025. Key support sits at ~$85 (the July swing low, being tested now), then a ~$70 historical accumulation zone (the November low), with a deeper level near ~$60. The analyst consensus target spans an enormous USD 45 to 250 — averaging near USD 135, well above the price — one of the widest disconnects in the market: the Street prices the $99B backlog, while the panel's value lenses price the leverage and the concentration. A decisive break below ~$85 opens room toward the ~$70 zone.
What legendary investors think
We ran CoreWeave past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue🔴 BearishHigh
"Not a moat — a treadmill you must keep sprinting on." Roughly $35B of debt plus ~$10B of leases against thin equity, ~$536M of quarterly interest, and billions of FCF burn against multi-billion capex. "A business renting hardware to a handful of hyperscalers who could build their own capacity anytime is a commodity supplier with a leased-up balance sheet, not a durable compounder." Pass.
The GARP OperatorGrowth (GARP)⚫ NeutralMedium
The growth is real — revenue +112% to $2.08B, backlog to $99.4B — "the kind of number that gets me interested in a fast grower." But "this isn't a PEG stock yet": no earnings, ~-$4.7B FCF in a quarter, and debt ballooned from ~$2B to ~$25-35B with ~$536M quarterly interest. "A company with cash and no debt almost always survives — CoreWeave is the opposite." Wants the backlog to convert to profit and leverage to fall first.
The Disruptive-Innovation SeekerGrowth🟢 BullishMedium
"The picks-and-shovels play on the AI inference/training S-curve." At ~$89 the stock trades far below the implication of a $99.4B backlog (up from ~$30B a year prior), anchored by ~$21B Meta and ~$22.4B OpenAI commitments across 3.5GW of contracted power — "multi-year visibility most cloud names lack." Reads the ~24%+ pullback as "a buyable dislocation," though concentration and capital intensity keep conviction at Medium, not High.
The Intrinsic-Value ModelerValuation🔴 BearishHigh
A DCF (revenue toward $12-13B decelerating as hyperscaler in-housing erodes the GPU-arbitrage moat, FCF negative for years on ~$7.7B quarterly capex, ~12-13% WACC for $25B+ debt and concentration) yields fair value ~$35-45 — roughly half the price. "The market is pricing near-flawless execution on a business whose moat is rented GPUs financed by debt against a small customer base. At $89 there is no margin of safety."
The Forensic SkepticContrarian🔴 BearishMedium
"The debt-financed depreciation treadmill is outrunning revenue." Q1 depreciation ($1.14B) plus interest ($536M) consumed ~80% of revenue before opex, debt ballooned from ~$8B to ~$25B, and the net loss widened to $740M. "The market prices the $99.4B backlog as de-risked; I read it as GPU-collateralized leverage against depreciating assets tied to two counterparties" — Microsoft ~67% of revenue. An asset-liability mismatch that already exists on the balance sheet.
The Macro OpportunistMacro🔴 BearishMedium
"Technical damage I won't fight." CRWV trades below its 50- and 200-day (a fresh death cross), down ~46% over a year and ~31% in a month, "inside a broader AI-capex question" as hyperscalers signal in-house buildout — "a structural, not cyclical, risk" to the third-party GPU-cloud thesis. Stays out until a reclaim of the 200-day on volume and hyperscaler capex reaffirming external demand.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The demand signal is real: revenue +112%, a $99.4B backlog with Microsoft, OpenAI, Meta, and Anthropic.
- The leverage is extreme: ~$25B+ debt (over $35B with leases), ~$2.1B annualized interest, billions of quarterly FCF burn.
- Concentration is acute and now realized: Microsoft (~two-thirds of revenue) de-prioritized CoreWeave for a rival.
- The tape is broken: below the 50- and 200-day, ~46% off the high.
The real debate
- Backlog as safety or as leverage? The innovation lens sees $99B of visibility; the value/forensic lenses see GPU-collateralized debt against depreciating assets and two counterparties.
- Does hyperscaler self-build end the model? The Microsoft-to-rival move is the bears' proof; the bull sees dislocation, not thesis break.
- Street vs. price: analyst targets near $135 imply ~50% upside; the panel's DCF implies ~50% downside — a rare, stark split, amplified by a ~32% short interest that can squeeze either way.
The question it comes down to: Is CoreWeave the indispensable, contract-backed GPU cloud of the AI era — or a debt-financed GPU landlord whose interest and depreciation already eat most of its revenue, whose biggest customer is walking, and whose fair value on the cash-flow math is roughly half today's price?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 88.88 / ~49B |
| Valuation | P/S ~5.9x; EV/revenue ~8.6x (unprofitable) |
| Q1 2026 revenue | USD 2.08B (+112% YoY); revenue backlog $99.4B |
| Net loss / margin | -$740M / ~-36% (widened from -$315M a year prior) |
| Interest expense | |
| Balance sheet | Debt ~$25B (over $35B incl. leases) vs cash ~$2.3B; multi-billion quarterly capex; FCF ~-$4.7B in Q1 |
| Customer concentration | Microsoft ~two-thirds of revenue (recently de-prioritized CoreWeave for a rival) |
Figures as of Q1 2026 (reported May 7, 2026) / July 11, 2026; sourced from CoreWeave IR/SEC filings, CNBC, StockAnalysis, Fierce Network, Alphastreet, S3 Partners, MarketBeat. Debt figures vary by source (~$24.9B per the Q1 10-Q vs higher including lease obligations) — leverage is extreme either way, with ~$2.1B annualized interest and negative FCF. The $99.4B backlog is real but concentrated (Microsoft ~two-thirds of revenue, which recently passed on expansion for a rival). Short interest is elevated (32% of float), adding two-sided volatility. Analyst consensus ($135 avg, range ~$45-250) sits well above the price. Next print: ~mid-August 2026.
The bottom line
CoreWeave is the panel's clearest sell-discipline call — a real demand story that five of six lenses believe a dangerous balance sheet and a departing anchor customer have turned into a poor risk. The bull case is not imaginary: revenue doubled to $2.08B, the backlog reached $99.4B with the biggest names in AI, and analysts still target ~$135 — roughly 50% above the price. But the panel's caution is concrete and, unusually, unanimous in direction among five members: roughly $25B of debt (more with leases), ~$2.1B of annual interest, a widening $740M loss, billions of quarterly cash burn, and — most tellingly — Microsoft, the source of about two-thirds of revenue, passing on expansion to sign with a rival, the exact concentration risk the model was built on. The intrinsic-value work lands near $35-45, about half the price, and the chart has broken down through its major averages. What would overturn the call is deleveraging plus proof the customer base is broadening — a reclaim of the 200-day on volume, and hyperscaler commitments that reaffirm external GPU demand rather than in-housing. What makes it a sell is that, today, buyers own a leveraged, concentrated, cash-burning GPU landlord priced at roughly twice the panel's cash-flow value while its largest customer walks — the backlog is real, but so is the debt, and the debt has a claim ahead of the equity.
contact@verdixhq.com · Published 2026-07-11 · Prices as of 2026-07-11 · Time horizon: 3–12 months · No direct position held in CRWV · CRWV verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s case against CRWV — and where they disagree.
The case against outweighs the case for at today's price.
NASDAQ · Technology / AI Cloud Infrastructure · 2026-07-18 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
SellHIGH confidence
Why
CoreWeave's panel goes from five-of-six bearish to a full sweep this week: the stock fell 17.6% to $73.21, breaking the $85 support flagged last week, while ~$25B of debt, ~$536M of quarterly interest, and a realized Microsoft customer-concentration risk keep every lens pointed the same way. The debate and the key levels.Level to watch
Key support 70−4.4% from 73.21
The panel's take
Verdict: SELL · Conviction: HIGH · Last price: USD 73.21 (as of 2026-07-18)
What changed since 2026-07-11:
- Price: USD 88.88 → 73.21 (-17.6%) — a sharp weekly decline that broke the $85 support flagged in the prior update, opening the door to the $70 historical accumulation zone.
- Panel: 5 of 6 → 6 of 6 now Bearish (The GARP Operator and The Disruptive-Innovation Seeker flipped bearish) — the lone bullish holdout turned as the financing structure itself became the story, and the previously Neutral GARP lens turned bearish on collapsing operating margin.
- Trigger: the mid-August print — whether it shows the $99.4B backlog converting into stabilizing cash flow and the debt load easing.
- Verdict: SELL (unchanged) — conviction raised from MEDIUM to HIGH.
The panel's synthesis stays SELL because nothing in the underlying financing picture improved — roughly $25B of debt, ~$536M of quarterly interest, and ~$4.7B of quarterly cash burn remain exactly where they were, only now compounded by a Microsoft customer-concentration risk that moved from a flagged possibility to a realized fact. With intrinsic-value work still anchored around $35-45, the synthesis holds — now with the full panel behind it rather than five of six.
Key levels
Key levels · CRWV
USD · as of 2026-07-18Analyst consensus target 135 USD · range 45–250
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance starts at the ~$85 level broken this week (now overhead supply on any bounce), then the ~$92 Supertrend trend line, up to the ~$124 five-day EMA left behind by the decline. Key support sits at the ~$70 historical accumulation zone, with a deeper level near ~$60 if that zone fails to hold. The analyst consensus target spans USD 45 to 250 around a $135 average, well above the price — the widest disconnect on the panel remains between Street targets and the panel's cash-flow-based value work.
What legendary investors think
We ran CoreWeave past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue/Quality/Moat🔴 BearishHigh
"This isn't a business I understand well enough to trust with $25 billion of debt" — $536M of quarterly interest and two-thirds of revenue tied to a customer that "just showed you the door in favor of a rival" turns a moat into "a landlord who can evict you." At ~8x EV/Revenue against an intrinsic estimate of $35-45, stays on the sidelines rather than catch a falling knife into 32% short interest and a refinancing wall.
The GARP OperatorGrowth (GARP)🔴 BearishHigh
"Burning $4.7B a quarter while carrying $25B in debt...that's not a business, that's a treadmill." The $99.4B backlog "sounds impressive on paper," but adjusted operating margin has collapsed from 17% to 1% and the net loss widened to $740M — "I want to see cash, not promises," and the tape is down 17.6% this week, breaking the $85 support right on schedule. Watches from the sidelines until the mid-August print.
The Disruptive-Innovation SeekerGrowth🔴 BearishMedium
The AI-infrastructure S-curve is real — a $99.4B backlog and 112% revenue growth prove the demand signal — but "the balance sheet architecture funding that growth" is eroding the cost-decline curve with $2.1B of annualized interest against ~$4.7B of quarterly burn. Losing two-thirds of revenue concentration to a Microsoft de-prioritization is "exactly the kind of platform-risk event" that shouldn't happen to an optionality bet, and the retest of the ~$70 zone with Supertrend still red says allocators aren't yet buying "temporary digestion."
The Intrinsic-Value ModelerValuation🔴 BearishMedium
"The story hasn't changed since last week, only the price has — and that's exactly the problem." With ~$2.1B of annualized interest against ~$4.7B of quarterly free-cash outflow, "the reinvestment math simply doesn't clear its cost of capital yet." Intrinsic value still lands around $35-45; the break of $85 support into the $70 zone is "technical confirmation of the fundamental thesis, not a new signal" — wants the mid-August print before treating any bounce as more than a relief rally.
The Forensic SkepticContrarian/Forensic🔴 BearishHigh
"I read the footnotes, and the footnotes here are $25B in debt, $536M in quarterly interest against a company burning $4.7B in FCF" — a "countdown clock into a mid-August refinancing wall." The Microsoft de-prioritization confirms the concentration risk, and the break through $85 into the $70 zone on 63.6M shares reads as "confirmed distribution," not capitulation. "I'm not covering until the August print either confirms the burn is stabilizing or validates the zero."
The Macro OpportunistMacro/Timing🔴 BearishHigh
"Liquidity and balance sheet strength matter more than the growth story" — $25B+ of debt, ~$4.7B of quarterly cash burn, and $536M of quarterly interest describe "a company being financed by hope, not cash flow." Supertrend has been red since April; the break of $85 support on 63.6M shares of volume "is distribution, not noise." With 32% short interest and no print until mid-August, calls this "dead money at best and a re-test of $60 at worst."
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All six lenses are bearish this week, up from five of six last week — even the disruptive-innovation lens, previously the lone bull, has turned bearish on the financing structure.
- The leverage is extreme: ~$25B of debt (over $35B with leases),
$536M of quarterly interest ($2.1B annualized), and ~$4.7B of quarterly free-cash-flow burn. - The Microsoft concentration risk flagged previously is now realized: roughly two-thirds of revenue tied to a customer confirmed to be diversifying to a rival.
- The tape confirmed the thesis technically: a 17.6% weekly decline broke the $85 support, on 63.6M shares of volume, opening the door to the ~$70 zone.
The real debate
- Dead money or an active short? The Forensic Skeptic and Macro Opportunist frame this as an avoid/short with a specific exit trigger (the mid-August print); the Disruptive-Innovation Seeker and Intrinsic-Value Modeler frame it as a business with real optionality that needs the print to confirm backlog-to-cash conversion before reconsidering.
- Does the backlog de-risk the debt, or collateralize it? The innovation lens still credits the $99.4B backlog and 112% growth as a genuine demand signal; the value and forensic lenses see the same backlog financed by debt whose interest already competes with operating cash flow.
- How far does this fall? The Macro Opportunist marks a specific downside level near $60 if the debt wall and next print collide; others frame the $70 zone as a historical accumulation band rather than a hard floor.
The question it comes down to: Does CoreWeave's mid-August print show the $99.4B backlog beginning to convert into stabilizing cash flow — or does the debt-service burden confirm that this is a leveraged compute lessor trading well above the panel's $35-45 intrinsic estimate?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 73.21 / ~$40B |
| Valuation | EV/Revenue ~8x (unprofitable) |
| Q1 2026 revenue | USD 2.08B (+112% YoY); revenue backlog $99.4B |
| Net loss / margin | -$740M / ~-36% |
| Interest expense | |
| Balance sheet | Debt ~$25B (over $35B incl. leases) vs cash ~$2.3B; FCF ~-$4.7B in Q1 |
| Customer concentration | Microsoft ~two-thirds of revenue (recently de-prioritized CoreWeave for a rival) |
Figures as of Q1 2026 (reported May 7, 2026) / July 18, 2026; sourced from CoreWeave IR/SEC filings, CNBC, StockAnalysis, Fierce Network, Alphastreet, S3 Partners, MarketBeat, and this week's panel commentary. Debt, interest, and cash-burn figures are unchanged from the last reported quarter — no new print has landed since. Short interest remains elevated (32% of float), adding two-sided volatility. Analyst consensus ($135 avg, range ~$45-250) sits well above the price. Next print: ~mid-August 2026.
The bottom line
What would tip the call back toward reconsideration is the mid-August print showing the $99.4B backlog beginning to convert into stabilizing operating cash flow and the debt load easing — evidence the model, not just the story, is de-risking. A break below the ~$70 historical accumulation zone toward the ~$60 level, on continued volume, would instead confirm the panel's downside case. Watch operating margin specifically: it has compressed from 17% to 1%, and a further slide toward zero or negative would undercut even the Disruptive-Innovation lens's remaining conviction in the category. Elevated short interest (~32% of float) means a surprise in either direction — a debt refinancing announcement or a customer-diversification update — could move the stock sharply before the print itself.
contact@verdixhq.com · Published 2026-07-18 · Prices as of 2026-07-18 · Time horizon: 3–12 months · No direct position held in CRWV · CRWV verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s case against CRWV — and where they disagree.
The case against outweighs the case for at today's price.
NASDAQ · Technology / AI Cloud Infrastructure · 2026-07-25 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
SellHIGH confidence
Why
CoreWeave's panel holds a full SELL sweep this week as price rallies into the $83-87 resistance band, gets rejected, and settles back at $71.88 inside the $66-74 zone flagged last week. Guidance missed Street's revenue number, a new competitive-risk headline (Meta's reported cloud ambitions) compounds the existing Microsoft concentration story, and the mid-August catalyst now has a firm date — August 18. The debate and the key levels.Level to watch
Key support 70−2.6% from 71.88
The panel's take
Verdict: SELL · Conviction: HIGH · Last price: USD 71.88 (as of 2026-07-25)
What changed since 2026-07-18:
- Price: USD 73.21 → 71.88 (-1.8%) — a modest net decline after an intraweek rally into resistance and a hard rejection. Note: the 2026-07-24 bar carries unusually low volume (~25.3M vs. a ~100-150M weekly norm) and an atypical date-stamp, so this week's close is treated as provisional rather than a confirmed new down (or up) week.
- Panel: 6 of 6 → 6 of 6 Bearish, conviction split unchanged (4 High, 2 Medium) — no persona flipped stance or conviction this week (see The Forensic Skeptic on a new chip-price hedging disclosure, and The Disruptive-Innovation Seeker on a ratings-agency outlook upgrade).
- Catalyst: the mid-August print now has a firm date — Q2 2026 earnings, August 18, 2026 — and Q2 revenue guidance ($2.45-2.6B, midpoint $2.53B) came in below the ~$2.69B Street consensus even as ~108% YoY growth holds; FY2026 guidance was reaffirmed at $12-13B.
- New risk: fresh reporting frames Meta's potential cloud/AI-infrastructure ambitions as a second concentration-style overhang on the $99B backlog, layered on top of the existing Microsoft diversification risk.
- Offsetting development: the first analyst upgrade since the selloff — a Buy call on 2026-07-22, though paired with a target cut to $126 from $131 — reads as a valuation call on the pullback, not a fundamentals call. Separately, price rallied into the R1 (83-87) band on 2026-07-20 and was rejected, confirming that resistance as live rather than theoretical.
- Verdict: SELL (unchanged) — conviction stays HIGH.
Nothing this week reverses the 2026-07-18 call. The tape did exactly what the panel's technical thesis implied — rallying into the $83-87 resistance band and getting rejected, back into the $66-74 zone it is now testing live rather than approaching from above. The balance sheet (~$25B debt, ~$536M quarterly interest, ~$4.7B quarterly burn) sits unchanged because no new print has landed since Q1; what is new is a second data point compounding the concentration risk (reported Meta cloud ambitions alongside the existing Microsoft diversification) and a soft guidance print against Street's number, partially offset by one analyst calling the pullback attractive on valuation grounds. With intrinsic-value work still anchored at $35-45 and the catalyst now dated to August 18, the panel's synthesis holds at SELL, HIGH conviction, unchanged from last week.
Key levels
Key levels · CRWV
USD · as of 2026-07-25Analyst consensus target 138 USD · range 45–250
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
This week's data confirms the R1 band (83-87) as live resistance rather than a theoretical target — price rallied into it on 2026-07-20 (high 85.37) and was rejected, closing back at 71.88. R3 is updated from last week's stale five-day EMA figure to a more durable structural marker: the ~100-110 shelf left behind by May 2026's support-turned-supply zone, with the ~117-122 mid-June high area as a further cap above that. R2 (~92) remains untested and unchanged. On the downside, price is now sitting inside the S1 (66-74) historical accumulation zone rather than approaching it, having printed a 68.51 low on 2026-07-13; S2 (~60) stays the next level if S1 fails to hold over coming weeks, and S3 remains without a clean chart level, with the panel's $35-45 intrinsic estimate as the nearest fundamentals-based reference below it. The analyst consensus average has moved to $138.03 (from roughly 37 analysts, range still near 45-250) — the gap between Street targets and the panel's cash-flow-based estimate has not narrowed.
What legendary investors think
We ran CoreWeave past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue/Quality/Moat🔴 BearishHigh
"A moat that a hyperscaler can just decide to build for itself was never a moat, it was a temporary shortage." Reported cloud ambitions from a second hyperscaler layer a fresh missing-moat data point on top of last week's Microsoft diversification; growth "financed by $2.1B of annualized interest against negative operating leverage isn't compounding, it's borrowing against a backlog." Stays on the sidelines into the August 18 print.
The GARP OperatorGrowth (GARP)🔴 BearishHigh
"Price keeps falling while the fundamentals sit frozen, which is not what a falling-knife bounce looks like." PEG "doesn't even compute cleanly" against a 1% operating margin, and this week's competitive headlines stack a second "biggest customers stop needing you" risk on top of the Microsoft story. Watching, not buying, until the August 18 print shows margin actually recovering.
The Disruptive-Innovation SeekerGrowth🔴 BearishMedium
"A cost curve funded by debt whose interest competes with the compute you're trying to scale is not the same thing as a cost curve funded by falling unit economics." The demand signal keeps strengthening — 112% trailing growth, a new $40B power buildout — and a positive-outlook nudge from a credit-ratings agency is a genuine incremental positive on refinancing risk, but it is not the cash-flow-stabilization proof the August 18 print still has to deliver.
The Intrinsic-Value ModelerValuation🔴 BearishMedium
"A backlog is a claim on future cash flow, not future cash flow itself." This week's round trip toward the low-$80s and back into the $71-80 range re-tests the same band flagged last week without moving the anchor; a widening set of hyperscalers "threatening to insource compute only lengthens the odds" the $99.4B backlog converts on the timeline the current ~8x EV/Revenue multiple assumes. Intrinsic estimate holds at $35-45.
The Forensic SkepticContrarian/Forensic🔴 BearishHigh
"You don't hedge chip prices if your cost structure has slack." Reports that CoreWeave is exploring derivatives to manage memory/storage chip-price risk read as an admission of thin margin for error, layered on $25B of debt and ~$4.7B of quarterly burn; this week's bounce off the ~$73 low reads as "consolidation ahead of the print, not a reversal." Not covering until August 18 confirms the burn is stabilizing or validates the zero.
The Macro OpportunistMacro/Timing🔴 BearishHigh
"When the tape breaks every level I've been watching and the parties financing the story start looking like future competitors, that's not a dip, that's the market repricing who actually has pricing power." Analysts chasing this with upgrades and triple-digit targets are pricing the growth story; watching the ~$60 level as the next real test on the way down, with a clean break there opening the door toward the $45 low end of the intrinsic range.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All six lenses remain Bearish this week, unchanged from a full 6-of-6 sweep last week.
- The leverage and burn profile is unchanged since the last report: ~$25B of debt, ~$536M of quarterly interest, ~$4.7B of quarterly free-cash-flow burn — no new print has landed since Q1.
- Two concentration-style risks now sit side by side: the realized Microsoft diversification and fresh reporting on a second hyperscaler's potential cloud-infrastructure build.
- The tape reinforced the thesis technically: a rally into the $83-87 band on 2026-07-20 was rejected, closing back near $71-72 inside the S1 accumulation zone.
The real debate
- Valuation-driven bounce or continued distribution? The week's lone analyst upgrade — a Buy call paired with a cut price target — reads to some as risk finally getting attractive after a steep decline; the panel majority reads the same move as pricing the growth story, not the balance sheet.
- Does the backlog de-risk the debt, or collateralize it? The Disruptive-Innovation Seeker still credits the $99.4B backlog and continued growth as a genuine demand signal, crediting a ratings-agency outlook improvement as incremental good news; the Moat Compounder, Forensic Skeptic, and Macro Opportunist see the same backlog financed by debt whose interest already competes with operating cash flow, now compounded by a second competitive threat.
- How far does this fall? The Macro Opportunist marks a specific downside level near $60 with $45 as the intrinsic floor if that breaks on volume; others frame the S1 (66-74) zone as the level to watch holding versus failing over the coming weeks, not a hard floor to call today.
The question it comes down to: Does CoreWeave's August 18 print show the $99.4B backlog beginning to convert into stabilizing cash flow — or does the debt-service burden, now compounded by a second reported competitive threat, confirm this is a leveraged compute lessor trading well above the panel's $35-45 intrinsic estimate?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 71.88 / ~$39B |
| Valuation | EV/Revenue ~8x (unprofitable) |
| Q2 2026 guidance | USD 2.45–2.6B revenue (midpoint $2.53B; ~108% YoY) vs. ~$2.69B Street consensus; FY2026 reaffirmed at $12–13B |
| Net loss / margin | -$740M / ~-36% (last reported, Q1 2026) |
| Interest expense | |
| Balance sheet | Debt ~$25B (over $35B incl. leases) vs. cash ~$2.3B; FCF ~-$4.7B in Q1 (unchanged, no new print) |
| Customer concentration / competitive risk | Microsoft ~two-thirds of revenue (diversifying to a rival); fresh reporting flags a second hyperscaler's potential cloud/AI-infrastructure build as an added overhang |
| Analyst consensus | ~37 analysts average Buy, 12-month target USD 138.03; one upgrade to Buy on 2026-07-22 paired with a target cut to $126 from $131 |
| Next print | Q2 2026 earnings, August 18, 2026 (confirmed date) |
Figures as of Q1 2026 (reported May 7, 2026) for debt, interest, burn, and margin; July 20–26, 2026 for price, guidance, and sentiment data. Sourced from CoreWeave IR/SEC filings, Yahoo Finance, CNBC, StockAnalysis, FX Leaders, StocksToTrade, GuruFocus, TipRanks/Investing.com, Fintel, and market-report coverage. Balance-sheet figures are unchanged from the last reported quarter — no new print has landed since. The 2026-07-24 weekly bar shows unusually low volume (~25.3M) and an atypical date-stamp and is treated as provisional pending next week's confirmation. Next print: August 18, 2026.
The bottom line
What would tip the call back toward reconsideration is unchanged: the August 18 print showing the $99.4B backlog beginning to convert into stabilizing operating cash flow, margin re-inflecting off its ~1% trough, and the debt load beginning to ease — evidence the model, not just the narrative, is de-risking. A close below the ~$66-74 accumulation zone toward the ~$60 level, especially on rising volume, would instead confirm the panel's downside case and open the door toward the $45 low end of the intrinsic range. Two developments this week complicate either outcome without resolving it: one analyst's Buy upgrade shows the market is willing to call the pullback attractive on valuation, while fresh reporting on a second hyperscaler's cloud ambitions adds a new concentration-style risk on top of the existing Microsoft story — a genuine offset and a genuine new risk arriving in the same week, netting out to no change in the panel's synthesis. With volume still elevated but no capitulation spike, the tape continues to read as orderly distribution rather than an exhausted low, so the panel keeps treating the August 18 print — not this week's stabilization — as the actual catalyst.
contact@verdixhq.com · Published 2026-07-25 · Prices as of 2026-07-25 · Time horizon: 3–12 months · No direct position held in CRWV · CRWV verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call CRWV yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · AI Cloud Infrastructure / Neocloud · 2026-08-01 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitHIGH confidence
Why
CoreWeave splits our panel: one bull bets on AI-infrastructure disruption at compressed multiples, while five skeptics point to a debt load of $32.9 billion, negative earnings, and a stock still searching for a bottom. The verdict is WAIT — the business thesis holds up, but the right price or a technical reversal hasn't arrived yet.Level to watch
Key support 63.8−11.1% from 71.77
The panel's take
Verdict: WAIT · Conviction: HIGH · Last price: USD 71.77 · Changed from SELL
What changed since 2026-07-25:
- Price: 71.88 → 71.77 (-0.15%)
- Panel: 0 of 6 → 1 of 6 now Bullish — composition also changed: added The Margin-of-Safety Hunter; removed The Moat Compounder
- Trigger: BUY trigger: a weekly close above EMA20 ($89.68) with a bullish MACD cross and flattening price action forming a Stage 1 base, OR a pullback into the $55-60 zone where The Intrinsic-Value Modeler's margin of safety appears. Downgrade to SELL trigger: any announced contract reduction from Microsoft or OpenAI, a debt-covenant breach, or a dilutive equity raise below $60.
- Verdict: SELL → WAIT
Last month's SELL verdict was driven by a panel with zero bullish voices and forensic/technical consensus that the downside wasn't fully priced. This month, the Disruptive-Innovation Seeker replaces the Moat Compounder and steps forward as a lone BUY — not because the business improved, but because the 60% price decline has compressed forward multiples to levels where innovation-disruption math starts to work if you have a 5-year horizon. Yet that single bull isn't enough: the two most constructive skeptics (Intrinsic-Value Modeler and Macro Opportunist) both like the business thesis but refuse to buy without either a pullback to $55–60 or a Stage 1 basing pattern, which keeps the verdict at WAIT rather than upgrading to BUY.
The structure is a BUY vs WAIT split, not BUY vs SELL. The sole bull (The Disruptive-Innovation Seeker) says buy now; The Intrinsic-Value Modeler explicitly says 'watch and wait, don't chase' and would buy at $55-60, while The Macro Opportunist wants a Stage 1 base first — both like the business thesis but object on price/timing, not on the business itself. Even the bears (The Forensic Skeptic, The GARP Operator, The Margin-of-Safety Hunter) acknowledge real revenue and backlog; their objections center on balance-sheet fragility, which is a business-quality concern but not a terminal condemnation. The technical-scout flags Stage 4 — a timing objection. Because price is the single blocker for the constructive voices and there is a specific trigger ($55-60 per The Intrinsic-Value Modeler, plus a Stage 1 basing pattern), WAIT dominates over HOLD.
Key levels
Key levels · CRWV
USD · as of 2026-08-01Key support & resistance — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance sits at $80.38-$95.45, key support at $55-$63.80, and an analyst consensus target was not available in this cycle's data.
What legendary investors think
We ran CoreWeave, Inc. past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralLow
Signal: At $72, the market is pricing in the base-case outcome with zero margin of safety — the estimated intrinsic value of $68–82 means upside is capped at roughly +14% while downside to the bear case is -50% ($35–45), making the asymmetry unfavorable. Conviction: Conviction is held back by one contested dependency: the entire valuation hinges on whether operating margins can reach 15% and gross margins hold above 55% as hyperscalers commoditize AI compute, and that operating leverage hasn't materialized yet.
The Forensic SkepticContrarian/Forensic🔴 BearishMed
Signal: The Altman Z-score of 0.21 puts CRWV firmly in the distress zone, and with net debt of $32.9B against a $44B equity market cap, even optimistic forward P/S of 1.3x on 2027 revenue implies just $52 per share — below the current $72 — meaning the balance-sheet risk isn't priced in. Conviction: Conviction is bolstered by multiple independent, hard-to-dispute facts: negative FCF of $10.6B, customer concentration at 77%, insider selling into weakness, and Stage 4 price action — each alone would raise flags, but together they form a consistent distress signal that's difficult to dismiss.
The GARP OperatorGrowth (GARP)🔴 BearishMed
Signal: With negative GAAP earnings making the PEG ratio incalculable and a debt-to-equity ratio of 7.39, this isn't an investment — it's a speculation on a story stock that fails the most basic The GARP Operator test: show me the earnings. Conviction: Conviction runs high because the failure is categorical, not marginal: no PEG ratio means The GARP Operator's entire framework cannot engage, and the balance sheet would 'give him ulcers' regardless of how compelling the AI growth story sounds.
The Disruptive-Innovation SeekerDisruptive Innovation🟢 BullishMed
Signal: With $6B in operating cash flow already flowing and forward EV/EBITDA collapsing to 8–10x on 2027 estimates, the market is discounting contracted, multi-year revenue as if material execution failure is certain — exactly the dislocation where innovation bets pay off. Conviction: Conviction is tempered by one unresolved dependency: the thesis works only if Microsoft and OpenAI remain strategic partners rather than building internal GPU capacity, and any sign of either doing so would break the entire 5-year $250 target.
The Margin-of-Safety HunterValue/Quantitative🔴 BearishHigh
Signal: CoreWeave fails 7 of 8 The Margin-of-Safety Hunter defensive-investor criteria — no 10-year earnings record, a current ratio of 0.31, and an incalculable The Margin-of-Safety Hunter Number — which means there is no margin of safety at any price until the business demonstrates proven, stable earning power. Conviction: Conviction is exceptionally high because the failure is structural: no amount of revenue growth can compensate for the absence of both positive GAAP earnings and a solvent balance sheet, which are prerequisites under The Margin-of-Safety Hunter's framework, not negotiable preferences.
The Macro OpportunistMacro/Timing🔴 BearishHigh
Signal: Price below all weekly EMAs, MACD accelerating lower, RSI at 40.76 with room to fall, and no reversal pattern — this is a textbook Stage 4 markdown in a tightening macro environment, and fighting the tape here would bet against both price and liquidity. Conviction: Conviction is reinforced by alignment across technicals, macro conditions, and fundamentals: the Fed's tightening bias makes refinancing $32.9B in debt harder, insider selling confirms weak confidence, and the absence of a Stage 1 base means there is no entry signal to contradict the bearish macro overlay.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- Revenue growth is real and impressive: $16M in 2022 to $6.2B LTM, backed by a $30B contracted backlog that provides multi-year visibility.
- Customer concentration is dangerously high: Microsoft and OpenAI together represent 77% of revenue, creating a binary dependency that every archetype flags.
- The balance sheet is fragile: D/E of 7.39, current ratio of 0.31, negative interest coverage, and net debt of $32.9B are undisputed facts no one dismisses.
- The stock is in a Stage 4 downtrend: price below all weekly EMAs, MACD deepening negative, and no bottoming pattern — the technical damage is visible to all.
The real debate
- The Disruptive-Innovation Seeker sees Microsoft and OpenAI as strategic partners with equity-like relationships that deepen the moat; the GARP Operator and Margin-of-Safety Hunter see them as a subcontractor-level dependency where losing one customer collapses the business.
- The Intrinsic-Value Modeler calculates a base-case value of $68–82 and says the stock is fairly priced but lacks a margin of safety; the Forensic Skeptic argues even optimistic 2027 P/S math yields only $52/share, meaning the market is still overpaying relative to balance-sheet risk.
- The Disruptive-Innovation Seeker treats $6B in operating cash flow as proof the model is already cash-generative and will inflect to positive FCF post-2028; the Macro Opportunist counters that $16.6B in annual CapEx funded by ever-more debt in a tightening cycle makes the cash flow argument a mirage until conditions loosen.
The question it comes down to: Can CoreWeave generate enough operating cash flow to service its $32.9B debt load and reach positive free cash flow before either a customer defection or a credit tightening forces a dilutive restructuring?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 71.77 / ~USD 44.2B |
| P/E (TTM / fwd) | -20.5 / n/a |
| ROE | -40.33% |
| Operating margin | -2.61% |
| Dividend yield | n/a |
| Debt / equity | 7.39 |
| Free cash flow | -USD 10.6B (LTM) |
Figures from the fundamental_scout research pull (2026-08-01); sourced from trefis.com, stockanalysis.com, and kaplio.com (trefis figures reflect a 2026-01-13 data pull; market cap figure per trefis.com's balance-sheet notes). Forward P/E and analyst consensus target were not available in this cycle's data.
The bottom line
The decisive trigger for upgrading to BUY is specific: either a weekly close above the EMA20 at $89.68 with a bullish MACD cross confirming a Stage 1 base has formed, or a pullback into the $55–60 zone where the Intrinsic-Value Modeler's margin of safety appears. On the downside, watch Q2 2026 earnings around September for any softening in backlog conversion or commentary about Microsoft/OpenAI contract renewals — those are the catalysts that could push the stock below $60 and toward the bear-case range of $35–45. The debt maturity schedule is the unspoken clock: the company must refinance or service obligations while CapEx stays elevated, so any covenant breach or dilutive raise below $60 would likely flip the panel to a SELL. For now, the asymmetry doesn't favor either direction yet — the stock needs time to either prove the skeptics wrong on margins or give them the price they demand.
contact@verdixhq.com · Published 2026-08-01 · Prices as of 2026-08-01 · Time horizon: 3–12 months · No direct position held in CRWV · CRWV verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s case against CRWV — and where they disagree.
The case against outweighs the case for at today's price.
NASDAQ · AI Cloud Infrastructure / Neocloud · 2026-08-08 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
SellHIGH confidence
Why
All six panelists see CoreWeave as a no-moat, debt-heavy commodity infrastructure play riding AI hype, not a sustainable technology business. With intrinsic value estimates clustering at $35-50 against a $90 price, insiders selling billions while the company burns $10.6 billion in annual free cash flow, and no path to GAAP profitability in sight, the panel unanimously calls SELL with high conviction, though they disagree on whether the stock could ever become investable at any price.Level to watch
Key resistance 95.94+5.8% from 90.67
Next catalyst
Trigger to confirm the bear case: A weekly close below the $78 high-volume POC would signal that accumulated speculative positions are capitulating, opening a path to the $63–66 range and potentially to the $33–50 zone where fundamental-value estimates cluster.The panel's take
Verdict: SELL · Conviction: HIGH · Last price: 90.67 · Changed from WAIT
What changed since 2026-08-01:
- Price: 71.77 → 90.67 (+26.33%)
- Panel: 1 of 6 → 0 of 6 now Bullish — composition also changed: added The Activist Catalyst, The Scuttlebutt Growth Investor; removed The Macro Opportunist, The Margin-of-Safety Hunter
- Trigger: A quarterly report demonstrating positive free cash flow or GAAP profitability; a credible deleveraging plan with D/E falling below 2.0x; development of proprietary technology that creates genuine switching costs; or a washout to $35–50 where price converges with the fundamental intrinsic-value estimates from The Intrinsic-Value Modeler and The Forensic Skeptic.
- Verdict: WAIT → SELL
The prior WAIT at $71.77 reflected a panel that included The Margin-of-Safety Hunter, whose price-discipline framework left room for a bullish turn if the stock approached intrinsic-value estimates. The 26% rally to $90.67, without any improvement in the underlying business fundamentals, eliminated that price-based counterargument entirely, while the addition of The Activist Catalyst and The Scuttlebutt Growth Investor reinforced the consensus: this is a fundamentally broken business model where a higher stock price only widens the downside risk.
The split is 7-to-1 business-objection dominant: The Intrinsic-Value Modeler, The Forensic Skeptic, The Activist Catalyst, The Scuttlebutt Growth Investor, The GARP Operator, The Disruptive-Innovation Seeker, and the fundamental scout all identify a no-moat, capital-intensive commodity business with $35B debt, negative interest coverage, and -$10.6B FCF. Intrinsic value estimates cluster at $35-50 versus roughly $90. The lone bull (the sentiment scout) leans on analyst consensus, which doesn't rebut the depth of fundamental deterioration.
Key levels
Key levels · CRWV
USD · as of 2026-08-08Key support & resistance — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran CoreWeave, Inc. past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Disruptive-Innovation SeekerDisruptive Innovation⚫ NeutralMed
Signal: CoreWeave is not a disruption story, it's a commodity infrastructure provider riding the AI buildout wave, with no proprietary technology, network effects, or data moats to protect its position against 200+ competitors and hyperscalers building their own capacity. Conviction: Several independent structural weaknesses converge to cap conviction on any bullish scenario: commodity positioning, $35B in debt with negative interest coverage, Wright's Law eroding the value of its installed GPU base, and $2.3B in insider selling.
The Intrinsic-Value ModelerValuation/DCF🔴 BearishMed
Signal: At a sales-to-capital ratio of ~0.40, CoreWeave must invest roughly $2.60 for every $1 of revenue, and even under optimistic margin assumptions, intrinsic value lands at $35-50, roughly half the current $90 price. Conviction: Three independent valuation methods (DCF, net asset value, and normalized earnings) all cluster at $35-50, while even the bull case barely reaches the current price. That's a rare convergence, and it's what raises confidence in the bearish call.
The Forensic SkepticContrarian/Forensic🔴 BearishMed
Signal: The balance sheet shows $35B in debt with negative interest coverage and a current ratio of 0.31, and insiders have sold over $1B in stock in 90 days, a combination where the margin of safety is not just absent but deeply negative. Conviction: Multiple uncorrelated sources reinforce the bearish signal: balance-sheet fragility, insider behavior, a technical breakdown below the 61.8% Fibonacci retracement, and competitive dynamics. Each independently points to the same conclusion.
The GARP OperatorGrowth (GARP)🔴 BearishMed
Signal: With no GAAP earnings, a debt-to-equity ratio of 7.39, and negative free cash flow of -$10.6B, this is a story stock where the PEG ratio can't even be calculated and the numbers don't support the narrative. Conviction: Only the $66B in booked contracts providing near-term revenue visibility tempers this, but the total absence of any countervailing positive signal (no earnings, no insider buying, no moat) keeps the bearish view intact.
The Scuttlebutt Growth InvestorGrowth/Management🔴 BearishMed
Signal: The scuttlebutt among cloud industry insiders is that wholesale GPU compute prices have already started declining as supply catches up, and CoreWeave's moat is thin: essentially just aggressive purchasing of Nvidia hardware that any well-capitalized competitor can replicate. Conviction: The company fails on too many of this archetype's 15-point checklist criteria at once, and that makes the bearish call unusually clear-cut: thin competitive advantages, unproven and likely volatile profitability, enormous capital needs, and a management vision that hasn't yet articulated a path beyond renting GPUs.
The Activist CatalystActivist/Capital Allocation🔴 BearishHigh
Signal: This business scores 2 out of 10 on quality, has no pricing power in a commodity market, and management has sold $2.3 billion in stock since lockup expiry, using the public market as an exit ramp rather than a vehicle for long-term value creation. Conviction: This sits near-maximum because the business fails every single investment criterion (quality, moat, cash flows, management alignment, and balance sheet), leaving no plausible bull case. Even an activist campaign would find nothing to salvage in a model that's broken by design.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All six panelists agree CoreWeave has no economic moat: GPU compute is a commodity service with 200+ competitors and hyperscalers (AWS, Azure, GCP) capable of undercutting on price at any time.
- All flag the $35B debt load as the central risk: a debt-to-equity ratio above 7.0, negative interest coverage, and a current ratio of 0.31 mean the company is entirely dependent on continuous external financing.
- All note that negative free cash flow of -$10.6B is not a temporary startup phase but a structural feature of the capital-intensive business model, where every dollar of revenue requires ~$2.60 in new investment.
- All observe that insider selling (over $2.3B since lockup expiry with zero insider purchases) is a signal that even the people closest to the business are reducing exposure.
- All acknowledge the AI TAM is real and growing, but agree that the winners will likely be platform owners (Nvidia, hyperscalers) rather than leveraged middlemen renting commoditized hardware.
The real debate
- The Intrinsic-Value Modeler and The Forensic Skeptic both see intrinsic value in the $35–50 range, implying the stock could become investable after a sufficient washout. The Activist Catalyst counters that the business model is broken by design and intrinsic value is effectively zero: the $35B debt overhang means equity could be worthless regardless of entry price.
- The Disruptive-Innovation Seeker assigns a 20% probability to a $250 bull case driven by AI demand explosion, acknowledging the TAM story has a non-trivial chance of playing out. The Activist Catalyst and The GARP Operator see even that scenario as a debt-fueled mirage requiring perpetual capital-market generosity that history says will not last.
- The Scuttlebutt Growth Investor would revisit the stock if either the price collapsed or the company demonstrated high and sustainable returns on invested capital, leaving the door open. The Activist Catalyst sees no price or condition at which the business becomes ownable, calling it a value trap rather than a turnaround.
The question it comes down to: Can CoreWeave generate positive free cash flow and build a genuine competitive advantage before its $35 billion debt load, or a cooling of AI capex spending, forces a reckoning that wipes out equity holders?
The bottom line
- Trigger to confirm the bear case: A weekly close below the $78 high-volume POC would signal that accumulated speculative positions are capitulating, opening a path to the $63–66 range and potentially to the $33–50 zone where fundamental-value estimates cluster.
- Next catalyst: Q2 earnings: any deceleration in revenue growth below 50% year-over-year or a gross-margin miss would expose the fixed-cost structure and could break the narrative that contracted revenue guarantees success.
- Risk to monitor: Any softening in AI CapEx guidance from Microsoft, Meta, or Amazon. CoreWeave's customer concentration means a single contract renegotiation or delay could cascade into covenant pressure across the debt stack.
- What would flip the call: A quarter of positive free cash flow combined with GAAP profitability, paired with insider buying of even a token amount, would directly challenge the bearish consensus that the business model cannot self-fund.
- Further out: If the stock washes out to the $35–50 range where The Intrinsic-Value Modeler and The Forensic Skeptic see value, the debate would shift from 'is this overvalued' to 'is the business survivable through a downturn,' a genuinely different question.
contact@verdixhq.com · Published 2026-08-08 · Prices as of 2026-08-08 · Time horizon: 3–12 months · No direct position held in CRWV · CRWV verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s case against CRWV — and where they disagree.
The case against outweighs the case for at today's price.
NASDAQ · AI Cloud Infrastructure / Neocloud · 2026-08-15 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
SellHIGH confidence
Why
Five investing archetypes break down CoreWeave after its 16% rally to $105 — and every fundamental voice lands on SELL, flagging 8.66x leverage, negative free cash flow, $50.7 million in insider selling, and a stock price that now sits above Morningstar's $97 fair value. The only disagreement is whether the $104 billion backlog justifies looking past the balance sheet or makes the debt load even more dangerous.Level to watch
Key support 103.86−1.3% from 105.26
Next catalyst
Trigger to cover a short: A weekly close above $110.26 (monthly 50% Fibonacci / volume POC zone) with MACD histogram turning positive would confirm that the correction has exhausted itself.The panel's take
Verdict: SELL · Conviction: HIGH · Last price: 105.26
What changed since 2026-08-08:
- Price: 90.67 → 105.26 (+16.09%)
- Panel: 0 of 6 → 0 of 5 now Bullish — composition also changed: added The Macro Opportunist, The Moat Compounder; removed The Activist Catalyst, The Disruptive-Innovation Seeker, The Scuttlebutt Growth Investor
- Trigger: To BUY: positive free cash flow on a trailing basis, debt-to-equity below 3x, and insider buying replacing insider selling — any two of those three. To cover a short: a weekly close above $110.26 (monthly 50% fib / POC zone) with MACD histogram turning positive, confirming the correction is over.
- Verdict: SELL (unchanged)
The prior panel at $90.67 also landed on SELL with high conviction, so the verdict holds — but the business-vs-price logic has sharpened. CoreWeave rallied 16% on a Q2 earnings beat that was still a loss of -$1.03 per share, and the panel's composition rotated away from the growth-oriented archetypes (The Disruptive-Innovation Seeker, The Scuttlebutt Growth Investor) toward voices that put balance-sheet durability front and center (The Moat Compounder, The Macro Opportunist). At $105 the stock now sits above Morningstar's $97 fair value with the same structural defects intact, making the SELL call more acute, not less.
The split is BUY vs SELL on genuine business-quality disagreement, not BUY vs WAIT. Only the technical-scout objects on PRICE/TIMING (neutral consolidation). Every fundamental voice — The Moat Compounder, The Intrinsic-Value Modeler, The GARP Operator, and The Forensic Skeptic — objects on BUSINESS grounds: no moat, 8.66x debt-to-equity, negative margins and FCF, $50.7M insider selling with zero buys, and valuation above Morningstar's $97 fair value. The sentiment-scout's bullishness is backed by analyst cheer and a Q2 beat, but even the beat was still a loss of -$1.03/share. When four high-conviction fundamentalists independently identify the same structural BUSINESS defects, and the lone bull is a sentiment aggregator (not a fundamental analyst), the net is decisively against at today's price. This is SELL, not BALANCED — the margin of safety is negative per The Intrinsic-Value Modeler ($82 base case, $45 bear) and The Forensic Skeptic ($30-$40 intrinsic), and the business risks are existential, not a matter of waiting for a better entry.
Key levels
Key levels · CRWV
USD · as of 2026-08-15Key support & resistance — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran CoreWeave, Inc. past a panel of 5 legendary investors' frameworks.
The panel · 5 investors
The Moat CompounderValue/Quality/Moat🔴 BearishHigh
Signal: A debt-to-equity ratio of 8.66 and a current ratio of 0.46 signal a balance sheet that leaves zero room for error, and without any economic moat, this is a commodity business where every dollar earned must be plowed straight back into GPU fleets just to stay in place. Conviction: Conviction is reinforced by three independent, hard-to-dispute facts: insiders sold $50.7 million with zero purchases, Morningstar assigns no moat, and the stock already trades above Morningstar's $97 fair value — a triple-lock against owning a low-quality business at a premium.
The Intrinsic-Value ModelerValuation/DCF🔴 BearishMed
Signal: The DCF base case lands at $82, a 22% discount to today's $105, and even the bull case of sustained 70% revenue growth with 35% terminal EBITDA margins barely scrapes $128 — meaning the current price already prices in near-perfect execution with no margin of safety. Conviction: Conviction is held in check by one contested assumption: whether the $104 billion backlog genuinely converts at high margins or whether hyperscaler competition and customer chip in-sourcing compress pricing before the revenue ramp fully materializes.
The GARP OperatorGrowth (GARP)🔴 BearishMed
Signal: The P/E is negative, so no PEG ratio can be computed, and without that core gauge the stock falls straight into the 'Too Hard' pile — unprofitable hypergrowth is a category this framework cannot underwrite. Conviction: Aggressive insider selling — $50.7 million in 90 days, zero buys, with the CEO dumping $10 million on the day of the earnings pop — removes any temptation to stretch the framework, because the people closest to the numbers are cashing out, not doubling down.
The Forensic SkepticContrarian/Forensic🔴 BearishMed
Signal: The gap between adjusted operating income (guided to $960M–$1.15B for FY2026) and deeply negative GAAP net income is a classic case of adjusted metrics hiding real economic costs: depreciation on a GPU fleet with a 4-year useful life and over $1 billion in annual interest expense are not accounting fictions. Conviction: What locks conviction is the capital-structure hair trigger — net debt near $46 billion against razor-thin tangible equity, with no moat to protect the revenue stream if a single major customer shifts to in-house silicon.
The Macro OpportunistMacro/Timing⚫ Neutraln/a
Signal: A company carrying 12x net debt-to-EBITDA with negative free cash flow is swimming directly against the macro current: tight credit conditions and a Fed that has held rates elevated into late 2026 punish exactly this kind of balance sheet, where every refinancing becomes a test of lender appetite. Conviction: Conviction is constrained by the possibility that AI infrastructure spending proves genuinely recession-resistant — if hyperscaler capex budgets hold through a slowdown, CoreWeave's revenue line could stay intact even as its funding costs rise, making the macro headwind a margin story rather than a solvency story.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- Every fundamental archetype agrees the balance sheet is dangerously leveraged: 8.66 debt-to-equity and 12x net debt-to-EBITDA are universally flagged as existential risk.
- No archetype disputes that insider behavior is a red flag — $50.7 million in selling with zero purchases, including the CEO's $10 million sale on earnings day.
- All five voices acknowledge that the revenue growth story is real and impressive, and the $104 billion backlog provides genuine visibility — the disagreement is solely about what that growth is worth given the capital structure and competitive dynamics.
- Morningstar's 'no moat' designation is accepted across the panel: CoreWeave lacks switching costs, proprietary technology, or network effects that would protect its economics as competitors scale up.
The real debate
- The Macro Opportunist sees the AI capex cycle as potentially durable through a slowdown, whereas The Moat Compounder and The Forensic Skeptic see a commodity business where any demand softening crushes the equity underneath a mountain of fixed obligations.
- The Intrinsic-Value Modeler's $82 base case is bearish but acknowledges a mathematically possible bull case at $128, while The Forensic Skeptic's $30–$40 intrinsic value estimate treats the entire enterprise as a debt instrument with a revenue tail — the spread between those two numbers is the real debate about whether the backlog is an asset or a trap.
- The GARP Operator refuses to play entirely because no P/E exists, while The Moat Compounder sees enough data (ROE, leverage, insider signals) to render a decisive verdict — the panel divides on whether missing metrics mean 'pass' or 'sell.'
The question it comes down to: Does a $104 billion contracted backlog justify paying above fair value for a no-moat, debt-heavy business that is still losing money on every share, or does the capital structure make the backlog itself a source of fragility?
The bottom line
- Trigger to cover a short: A weekly close above $110.26 (monthly 50% Fibonacci / volume POC zone) with MACD histogram turning positive would confirm that the correction has exhausted itself.
- What flips the fundamental call: Any two of these three would shift the panel toward BUY: positive trailing free cash flow, debt-to-equity below 3x, and insider buying replacing the current pattern of insider selling.
- Q3 2026 earnings (November 2026): If revenue growth decelerates from the guided 158% pace, the fixed-cost structure — depreciation and interest — will crush whatever adjusted EBITDA the company reports, validating the bear case rapidly.
- Customer concentration risk: Meta represents an outsized share of the $104 billion backlog; any signal that Meta is accelerating its in-house silicon program (MTIA chips) would force a re-rating of the entire backlog's durability.
- Credit-market trigger: A 100-basis-point rise in the Fed's benchmark rate from current levels would squeeze the interest-coverage math on $46 billion in net debt, turning a margin-compression story into a solvency question.
contact@verdixhq.com · Published 2026-08-15 · Prices as of 2026-08-15 · Time horizon: 3–12 months · No direct position held in CRWV · CRWV verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s split verdict on CRWV — and where they disagree.
The case for and against roughly balance — no clear edge at today's price.
NASDAQ · AI Cloud Infrastructure / Neocloud · 2026-08-22 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
BalancedMEDIUM confidence
Why
CoreWeave's 150% revenue growth and $104 billion AI-cloud backlog face off against a 10.27x debt-to-equity ratio and negative $13.66 billion in free cash flow. Our panel splits between one Bull who sees an exponential adoption curve, two Neutrals who value the stock near $78, and two Bears who warn the capital structure could wipe out equity holders. The verdict lands at BALANCED: the selloff from $105 has brought price toward fair value, but the triggers to buy have not yet fired.Level to watch
Key resistance 91.07+3.7% from 87.85
Next catalyst
Key support to hold: A weekly close below $78.28 (the weekly POC) on expanding volume would confirm the bear-flag breakdown and open a path toward $66, likely triggering a downgrade to SELL.The panel's take
Verdict: BALANCED · Conviction: MEDIUM · Last price: 87.85 · Changed from SELL
Panel: 1 Bullish · 2 Neutral · 2 Bearish → BALANCED
What changed since 2026-08-15:
- Price: 105.26 → 87.85 (-16.54%)
- Panel: 0 of 5 → 1 of 5 now Bullish — composition also changed: added The Asymmetric Bargainer, The Disruptive-Innovation Seeker; removed The Macro Opportunist, The Moat Compounder
- Trigger: BUY on a weekly close above $96.20 (EMA50) with the MACD histogram turning positive, confirming the Stage 4 downtrend is reversing. Alternatively, SELL on a weekly close below $78.28 (weekly POC) on expanding volume, confirming the bear-flag breakdown and targeting $66.
- Verdict: SELL → BALANCED
The prior SELL verdict at $105.26 was driven by a panel with zero bullish voices, where the intrinsic-value and GARP frameworks both saw overvaluation and the Forensic Skeptic flagged the balance sheet as existential. The stock has since fallen 16.5% to $87.85, moving into the $78-80 zone where the value-oriented framework now sees fair value but not yet a bargain. The trigger to flip to BUY, positive free cash flow, D/E below 3x, or insider buying, has not fired, and the addition of the Disruptive-Innovation Seeker as a lone Bull is offset by two Bears now framing the downside in more explicit terms. The panel shifted from unanimous caution to a genuine split, downgrading conviction from HIGH to MEDIUM and the verdict from SELL to BALANCED.
The prior SELL verdict at $105.26 is affirmed in spirit — the stock has fallen 16.5% to $87.85 — but the trigger to BUY (two of: positive FCF, D/E below 3x, insider buying) has NOT FIRED: FCF remains -$13.66B, D/E sits at 10.27x, and insiders are still selling, not buying. Price has moved through the $78-80 zone where The Intrinsic-Value Modeler and The GARP Operator see fair value but not yet to levels where the cautious voices would step in. With one Bull (The Disruptive-Innovation Seeker) against two Neutrals and two Bears, the panel cannot reach conviction in either direction at this price — BALANCED, waiting for either a break above $97 (trend repair) or a pullback toward $78 (value entry).
Key levels
Key levels · CRWV
USD · as of 2026-08-22Analyst consensus target 138.37 USD · range 36–303
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance sits at $92.33–96.20 (the weekly EMA20/EMA50 band, which must be recaptured to invalidate the Stage 4 downtrend), with the monthly POC at $91.07 just below it forming a tight overhead supply cluster. Above that, the $106.88–110.26 zone is the monthly 50% Fibonacci and prior short-cover trigger from the last article, now a major resistance wall. Key support rests at $78.28–80.38 (weekly POC and 78.6% Fibonacci, the floor of the current consolidation where both The Intrinsic-Value Modeler and The GARP Operator see entry value), with the $63.80–66.36 zone as the next downside target if that floor breaks. The analyst consensus target of $138.37 sits 57% above the current price, reflecting the wide dispersion between the bull case and the balance-sheet reality the Bears are flagging.
What legendary investors think
We ran CoreWeave, Inc. past a panel of 5 legendary investors' frameworks.
The panel · 5 investors
The Disruptive-Innovation SeekerDisruptive Innovation🟢 BullishMed
Signal: Revenue compounding at 150%+ and a $104 billion contract backlog with Meta, Anthropic, and Microsoft confirm CoreWeave sits at the center of the AI infrastructure buildout, and the operating-cash-flow inflection to $6.9B TTM signals the business is scaling toward self-funding growth well before traditional metrics capture it. Conviction: Conviction is held back by one unresolved dependency: the debt structure (10.27x D/E, 0.08x interest coverage) turns a thesis about exponential adoption into a binary outcome where any credit-market disruption could force dilution or restructuring before the S-curve plays out.
The GARP OperatorGrowth (GARP)⚫ NeutralLow
Signal: The top line is undeniable at 150% growth with $104 billion in backlog, but I cannot compute the PEG ratio, the core tool in my framework, because there are no earnings and the path to profitability keeps getting pushed further out with FY2026 EPS estimates sliding from -$4.55 to -$5.20 in two months. Conviction: Confidence stays low because insiders are selling hard (CEO unloaded $9.7M on the day of the earnings beat) and the balance sheet shows a current ratio of 0.46, meaning I would be betting on debt-market access rather than business fundamentals.
The Forensic SkepticContrarian/Forensic🔴 BearishMed
Signal: Free cash flow of negative $13.66 billion on operating cash flow of $6.9B means the company is a fundraising machine burning $20.6B in annual capex, and with a debt-to-equity ratio of 10.27x plus interest coverage of 0.08x, the equity is a call option on capital markets staying open. Conviction: What pushes conviction higher is the convergence of multiple independent red flags: insider selling of $9.7M on a beat-and-raise quarter, EPS estimates deteriorating 14% in 60 days despite revenue growth, and a Stage 4 downtrend in the chart, none of which require disputed assumptions.
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralLow
Signal: A DCF built on 55% revenue CAGR stepping down to 10% terminal growth, 11% WACC, and $23 billion in net debt produces a base-case value around $78, roughly 11% below the current price, and even the bull case at 70% sustained CAGR with 25% terminal EBITDA margins only reaches $120. Conviction: Conviction is tempered because the DCF depends entirely on the financing path: if credit markets stay accommodative and cap-ex intensity declines as modeled, the bear case at $48 recedes, but the current interest-coverage ratio of 0.08x makes that assumption fragile.
The Asymmetric BargainerContrarian/Deep Value🔴 BearishLow
Signal: The Dhandho framework flags a downside of 60% to 80% (toward the $36 low-analyst target) with 40% probability, because debt-to-equity of 10.27x and a current ratio of 0.46 mean any revenue deceleration below 50% growth could trigger a liquidity spiral within quarters. Conviction: Confidence is low because the key variable, whether credit markets remain open long enough for the revenue base to catch up to the debt load, is unobservable until it breaks, and the CEO selling $9.7M into a beat-and-raise quarter suggests the person closest to the books is not waiting to find out.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All five archetypes agree the revenue growth is real and exceptional (150%+ YoY, $104B backlog) and that the AI infrastructure demand narrative has genuine substance.
- All five recognize the balance sheet as the central risk: debt-to-equity of 10.27x, interest coverage near zero, and negative free cash flow of $13.66B make this a capital-structure story as much as a growth story.
- All five flag insider selling, particularly the CEO's $9.7M sale on earnings day, as a signal that contradicts bullish management commentary.
- The three valuation-oriented archetypes (GARP Operator, Intrinsic-Value Modeler, Asymmetric Bargainer) independently converge on a fair-value zone near $78, below the current $87.85.
The real debate
- The Disruptive-Innovation Seeker sees the $104B backlog and positive operating cash flow as evidence the business is hitting an inflection point where growth outruns the debt; The Forensic Skeptic sees the same numbers and concludes the company is a pass-through vehicle borrowing to buy depreciating GPUs, with equity holders absorbing all downside.
- The Intrinsic-Value Modeler estimates fair value at $78 and wants a pullback before committing; The Disruptive-Innovation Seeker would take exposure now on a five-year horizon because traditional DCF frameworks miss exponential adoption curves, producing a Bull-versus-Neutral split even though both acknowledge the same debt risk.
- The GARP Operator calls this a binary bet where ten-bagger potential exists but 100% loss is possible; The Asymmetric Bargainer frames the same trade as a negative expected-value position because the downside dwarfs the upside, a disagreement not on the facts but on how to weight the probability distribution.
The question it comes down to: Can CoreWeave's revenue base grow into its debt load before credit markets or customer demand shift, or does the capital structure make the equity uninvestable at any price above tangible book?
The bottom line
- Key support to hold: A weekly close below $78.28 (the weekly POC) on expanding volume would confirm the bear-flag breakdown and open a path toward $66, likely triggering a downgrade to SELL.
- Trigger to confirm the reversal: A weekly close above $96.20 (the 50-week EMA) with the MACD histogram turning positive would signal the Stage 4 downtrend is broken, clearing the way for a BUY verdict.
- Next catalyst: Q3 2026 earnings: Due November 2026, the Q3 report will test whether the EPS-revision trend (estimates cut 14% in 60 days) reverses; a GAAP profit surprise or a capex-intensity decline would shift conviction across the panel.
- Credit-spread risk to monitor: The high-yield/IG credit spread index (currently 0.751, up 2% over 13 weeks) is the canary: a spike above 0.85 would raise refinancing costs and accelerate the bear case by threatening the debt-market access the entire thesis depends on.
- Further out: free cash flow inflection: If capex normalizes toward 12% of revenue as the Intrinsic-Value Modeler projects and operating cash flow continues compounding, a quarter with positive free cash flow would resolve the single largest objection from all four cautious voices.
contact@verdixhq.com · Published 2026-08-22 · Prices as of 2026-08-22 · Time horizon: 3–12 months · No direct position held in CRWV · CRWV verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel also debated